Press/Media
- 25 - 50 out of 817 results
Search results
-
-
New Multiple Myeloma Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Interventions and Outcomes of Patients With Multiple Myeloma Receiving Salvage Therapy After Bcma-directed Car T Therapy)
David Melnekoff, Joshua Richter, Samir Parekh, Sundar Jagannath & Ajai Chari
13/04/23
1 item of Media coverage
Press/Media
-
Research from Icahn School of Medicine Mount Sinai Provide New Insights into Liver Fibrosis (Environmental exposures are important risk factors for advanced liver fibrosis in African American adults)
Andrea Branch, Meena Bansal & Amreen Dinani
11/04/23
1 item of Media coverage
Press/Media
-
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
22/03/23
1 item of Media coverage
Press/Media
-
Study Findings from Icahn School of Medicine at Mount Sinai Provide New Insights into COVID-19 (Molecular States During Acute Covid-19 Reveal Distinct Etiologies of Long-term Sequelae)
Noam Beckmann, Lauren Lepow, Kai Nie, Seunghee Kim-Schulze, Girish Nadkarni, Eric Schadt, Robert Sebra, Panagiotis Roussos, Benjamin Glicksberg, Alexander Charney, Sacha Gnjatic, Gabriel Hoffman & Miriam Merad
17/03/23
1 item of Media coverage
Press/Media
-
Data on Liver Cancer Detailed by Researchers at Icahn School of Medicine at Mount Sinai (Unannotated Small Rna Clusters Associated With Circulating Extracellular Vesicles Detect Early Stage Liver Cancer)
Parissa Tabrizian, Robert Sebra, Myron Schwartz, Navneet Dogra & Augusto Villanueva Rodriguez
16/03/23
1 item of Media coverage
Press/Media
-
Influenza B, the third wave of respiratory viruses this season
7/03/23
1 item of Media coverage
Press/Media
-
Mechanisms Underlying Autoimmunity in Down Syndrome Revealed
Dusan Bogunovic & Sacha Gnjatic
22/02/23 → 23/02/23
40 items of Media coverage
Press/Media
-
In a 1st, scientists grow stem cells that could show how bats harbor lethal viruses without dying
23/02/23
1 item of Media coverage
Press/Media
-
News Bat Induced Pluripotent Stem Cells Created Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and
Adolfo Garcia-Sastre & Thomas Zwaka
23/02/23
1 item of Media coverage
Press/Media
-
Mount Sinai: Mechanisms Underlying Autoimmunity in Down Syndrome Revealed
Dusan Bogunovic & Sacha Gnjatic
22/02/23 → 23/02/23
2 items of Media coverage
Press/Media
-
Mechanisms underlying autoimmunity in Down syndrome revealed
Dusan Bogunovic & Sacha Gnjatic
22/02/23
5 items of Media coverage
Press/Media
-
Mechanisms Underlying Autoimmunity in Down Syndrome Revealed.
Dusan Bogunovic & Sacha Gnjatic
22/02/23
1 item of Media coverage
Press/Media
-
First Stem Cells From a Bat Species Known to Harbor SARS-CoV-2 Could Shed Light on Virus Survival and Molecular Adaptability
Adolfo Garcia-Sastre & Thomas Zwaka
21/02/23
1 item of Media coverage
Press/Media
-
First stem cells from a bat species known to harbor SARS-CoV-2 could shed light on virus survival and molecular adaptability
Adolfo Garcia-Sastre & Thomas Zwaka
21/02/23
4 items of Media coverage
Press/Media
-
Researchers study first stem cells from a bat species known to harbor SARS-CoV-2
Adolfo Garcia-Sastre & Thomas Zwaka
21/02/23
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Cancer Described (Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics)
Kenen Onel & Sacha Gnjatic
15/02/23
1 item of Media coverage
Press/Media
-
US Patent Issued to Icahn School of Medicine at Mount Sinai on Feb. 14 for "Method of predicting graft versus host disease" (New York Inventors)
14/02/23
1 item of Media coverage
Press/Media
-
-
Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask
4/02/23
1 item of Media coverage
Press/Media
-
Cell BioEngines Enters into Licensing Agreement with Icahn School of Medicine at Mount Sinai
27/01/23
1 item of Media coverage
Press/Media
-
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
25/01/23 → 26/01/23
93 items of Media coverage
Press/Media
-
Cell Bioengines Enters Into An Exclusive Worldwide Agreement To Develop And Commercialize Potent Immune Cell States To Cure Cancer
25/01/23
1 item of Media coverage
Press/Media